IP Library Granted Patent US 7,964,635
Granted Patent B2
US 7,964,635 · App. 12/350,701 · Granted Jun 21, 2011

Amidoacetonitrile derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,635
App. No.
12/350,701
Granted
Jun 21, 2011
Kind
B2
Abstract

The invention relates to compounds of the general formula (I) wherein X, Y and W have the significances given in claim 1 and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites in and on warm-blooded animals.

Claims (24)

1. A composition for the control of parasites, comprising a compound of formula I

or a salt thereof, wherein

X is Cl, Br, or CF 3 ;

Y is a single bond, O, S, S(O), or S(O) 2 ; and

W is O or S;

and one or more carrier or dispersant.

2. The composition according to claim 1 , further comprising an effective amount of a natural or chemically modified macrocyclic lactone of formula A

wherein X is —CH(OH)—; —C(O)—; or —C(═N—OH)—;

Y is —CH 2 —; ═CH—; —CH(OH)—; or —C(═N—OCH 3 )—;

R 1 is hydrogen or one of radicals

wherein R 4 is hydroxyl, —NH—CH 3 , or —NHOCH 3 ;

R 2 is hydrogen, —CH 3 , —C 2 H 5 , —CH(CH 3 )CH 3 , —CH(CH 3 )C 2 H 5 , —CH(CH 3 )═CH—CH(CH 3 ) 2 , or cyclohexyl; and

the depicted dashed bond between atoms 22 and 23 may be a single or a double bond;

where if the depicted dashed bond is a double bond, then Y is ═CH—, and

where if the depicted dashed bond is a single bond, then Y is —CH 2 —, —CH(OH)—, or —C(═N—O—CH 3 )—,

or a physiologically acceptable salt thereof.

3. The composition according to claim 2 , wherein the macrocyclic lactone is a compound of the formula A, wherein

X is —CH(OH)—;

Y is —CH 2 —;

R 1 is the radical

R 2 is —CH 3 or —C 2 H 5 ; and

the bond between atoms 22 and 23 represents a single bond.

4. The composition according to claim 2 , wherein the macrocyclic lactone is selected from the group consisting of avermectins, milbemycins, and derivatives thereof, in free form or in the form of a physiologically acceptable salt.

5. The composition according to claim 2 , wherein the macrocyclic lactone is selected from the group consisting of Ivermectin, Doramectin, Moxidectin, Selamectin, Emamectin, Eprinomectin, Milbemectin, Abamectin, Milbemycin oxime, Nemadectin, and a derivative thereof, in free form or in the form of a physiologically acceptable salt.

Assignments (3)
CHANGE OF NAME Recorded Aug 25, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043402/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 034926/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2011
From: GOEBEL, THOMAS; GAUVRY, NOELLE; DUCRAY, PIERRE; PAUTRAT, FRANCOIS; KAMINSKY, RONALD; JUNG, MARTIN
To: NOVARTIS AG
Reel/Frame 025597/0312 →